Trial Details
COMPLETEDBasic Information
| Clinical ID | c1723 |
|---|---|
| Identifier | NCT05796245 |
| Trial Title | A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Arthritis, Rheumatoid|Colitis, Ulcerative|Crohn Disease|Psoriasis |
| Interventions | - |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Tokyo |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2023-12-01 |
|---|---|
| Primary Completion Date | 2024-03-14 |
| Completion Date | 2024-03-14 |